Razmjoo, Sasan, et al. “Real-World Clinical Outcomes of Low Dose Versus Standard Dose Abiraterone in Patients With Metastatic Castration-Resistant Prostate Cancer: A Prospective Pragmatic Study”. Asian Pacific Journal of Cancer Biology, vol. 9, no. 4, Oct. 2024, pp. 447-54, doi:10.31557/apjcb.2024.9.4.447-454.